AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 81 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $25,086,000 | +587.5% | 419,221 | +222.7% | 0.01% | +400.0% |
| Q3 2019 | $3,649,000 | -20.8% | 129,902 | +4.8% | 0.00% | 0.0% |
| Q2 2019 | $4,610,000 | -7.9% | 123,896 | -3.4% | 0.00% | 0.0% |
| Q1 2019 | $5,005,000 | +93.8% | 128,266 | +5.9% | 0.00% | 0.0% |
| Q4 2018 | $2,583,000 | -44.4% | 121,152 | +3.3% | 0.00% | 0.0% |
| Q3 2018 | $4,644,000 | +6.7% | 117,284 | +2.9% | 0.00% | 0.0% |
| Q2 2018 | $4,354,000 | +26.3% | 113,953 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $3,448,000 | -9.7% | 114,741 | -6.1% | 0.00% | 0.0% |
| Q4 2017 | $3,817,000 | +66.5% | 122,144 | +58.2% | 0.00% | 0.0% |
| Q3 2017 | $2,292,000 | +42.6% | 77,200 | -8.1% | 0.00% | – |
| Q2 2017 | $1,607,000 | -14.2% | 84,005 | -23.6% | 0.00% | – |
| Q1 2017 | $1,873,000 | -17.2% | 109,925 | -11.2% | 0.00% | -100.0% |
| Q4 2016 | $2,263,000 | -2.7% | 123,840 | -5.2% | 0.00% | 0.0% |
| Q3 2016 | $2,325,000 | – | 130,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |